EUVIMEDEUVIMED entdecken
Crossref

Functional impact of PROC variants on splicing and protein C activity: evidence for clinical reclassification and RNA therapeutic approaches

Huayang Zhang, Fei Huang, Ying Zhao, Baishen Pan, Chong Wang, Meixiu Gu, Chunyan Zhang, Wei Guo, Beili Wang

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2026.02.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Huayang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Protein C, RNA Splicing, Genetic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inherited protein C deficiency is an established genetic risk factor for venous thromboembolism. The pathogenic relevance and clinical interpretation of exonic and near-splice PROC variants, however, remain poorly understood. OBJECTIVES: We systematically investigated 15 PROC variants located at exon-intron boundaries (±20 bp) or within coding regions, integrating splicing, protein function, and computational prediction to refine variant classification and explore RNA-based correction. METHODS: Variant effects on splicing and protein function were first evaluated using in silico prediction. Experimental validation included minigene splicing assays, rescue with engineered U1 and U7 snRNAs, and analyses of protein expression, secretion, and activity, complemented by structural modeling. Five splicing prediction tools were benchmarked against experimental data, and findings were incorporated into the American College of Medical Genetics and Genomics/Association for Molecular Pathology framework. RESULTS: Several variants induced complex splicing defects, including exon skipping, activation of cryptic donor sites, and generation of multiple aberrant isoforms. SpliceAI provided the best binary prediction of splice disruption, although it underestimated isoform diversity. Some exon-edge variants exerted combined effects on splicing and protein function. Integration of transcript- and protein-level data enabled reclassification of previously uncertain variants. Both U1 and U7 snRNAs partially restored normal splicing in selected cases, demonstrating the feasibility of splice-directed correction. CONCLUSION: Exonic and near-splice PROC variants constitute a heterogeneous group of pathogenic alleles that are often missed by in silico prediction. Functional assays at both RNA and protein levels enhance American College of Medical Genetics and Genomics/Association for Molecular Pathology-based variant classification and support the development of RNA-targeted therapeutic approaches in hereditary thrombophilia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein CRNA SplicingGenetic TherapyHumansExonsRNA, Small NuclearIntronsGenetic Predisposition to DiseaseGenetic VariationPhenotypeComputer SimulationAlternative Splicing

Stichwörter der Autor:innen

ACMG/AMP classificationPROC geneRNA therapeuticsfunctional assaysprotein C deficiencysplicing variants

Substanzen

Protein CRNA, Small NuclearU1 small nuclear RNA

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Laboratory Medicine, Shanghai Geriatric Medical Center, Shanghai, China. Electronic address: zhang.chunyan@zs-hospi…
  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Laboratory Medicine, Shanghai Geriatric Medical Center, Shanghai, China; Department of Laboratory Medicine, Wusong…

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, H., Huang, F., Zhao, Y., Pan, B., Wang, C., Gu, M., Zhang, C., Guo, W., & Wang, B. (2026). Functional impact of PROC variants on splicing and protein C activity: evidence for clinical reclassification and RNA therapeutic approaches. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.02.011

Vancouver

Zhang H, Huang F, Zhao Y, Pan B, Wang C, Gu M, et al. Functional impact of PROC variants on splicing and protein C activity: evidence for clinical reclassification and RNA therapeutic approaches. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.02.011

BibTeX
@article{Zhang2026,
  author = {Zhang, Huayang and Huang, Fei and Zhao, Ying and Pan, Baishen and Wang, Chong and Gu, Meixiu and Zhang, Chunyan and Guo, Wei and Wang, Beili},
  title = {Functional impact of PROC variants on splicing and protein C activity: evidence for clinical reclassification and RNA therapeutic approaches},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2026.02.011}
}
Kostenlos starten →